@prefix p: <http://www.wikidata.org/prop/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema1: <http://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix wd: <http://www.wikidata.org/entity/> .
@prefix wds: <http://www.wikidata.org/entity/statement/> .
@prefix wdt: <http://www.wikidata.org/prop/direct/> .
@prefix wdtn: <http://www.wikidata.org/prop/direct-normalized/> .
@prefix wikibase: <http://wikiba.se/ontology#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

wd:Q581334 rdfs:label "فلوتاكيزون/سالميتيرول"@ar,
        "فلوتيكاسون بروبيونات / سالميتيرول"@azb,
        "Fluticason/Salmeterol"@bar,
        "Fluticason/Salmeterol"@de,
        "fluticasone/salmeterol"@en,
        "fluticasona-salmeterol"@es,
        "Sérétide"@fr,
        "サルメテロール・フルチカゾン"@ja,
        "플루티카손/살메테롤"@ko,
        "salmeterol"@ku-arab,
        "flutikason–salmeterol"@nn,
        "ଫ୍ଲୁଟିକାସୋନ/ସାଲମେଟେରୋଲ"@or,
        "seretide"@ro,
        "Flutikazon/salmeterol"@sh,
        "flutikazon/salmeterol"@sl,
        "Flutikazon/salmeterol"@sr,
        "Fluticasone/salmeterol"@vi,
        "丙酸氟替卡松/沙美特羅"@zh ;
    schema1:dateModified "2026-01-08T22:18:14+00:00"^^xsd:dateTime ;
    schema1:description "Kombinationspräparat gegen Asthma und COPD"@de,
        "formulation used in the management of asthma and chronic obstructive pulmonary disease"@en,
        "formulación utilizada en el tratamiento del asma y de la enfermedad pulmonar obstructiva crónica"@es,
        "քիմիական միացություն"@hy,
        "eit kombinasjonsmedikament brukt til behandling av astma og kols"@nn,
        "ଆଜ୍ମା ରୋଗରେ ଦିଆଯାଏ ।"@or ;
    schema1:version 2452972516 ;
    wikibase:identifiers 23 ;
    wikibase:sitelinks 14 ;
    wikibase:statements 38 ;
    skos:altLabel "fluticasone / salmeterol"@en,
        "fluticasone-salmeterol"@en,
        "salmeterol / fluticasone"@en,
        "salmeterol / fluticasone propionate"@en,
        "propionato de fluticasona-salmeterol"@es,
        "flutikason og salmeterol"@nn,
        "flutikason-salmeterol"@nn,
        "flutikason/salmeterol"@nn ;
    p:P10245 wds:Q581334-0aee3afd-4e8b-2231-5994-3d30f1781681 ;
    p:P11089 wds:Q581334-4A40B089-D11F-40B4-9E0D-0DC1178D40A6 ;
    p:P11143 wds:Q581334-489A7310-8D43-44C1-A1EE-E5F9E570E5F3 ;
    p:P2017 wds:Q581334-17BD5AFC-C788-47D3-8BF9-22BBAB60B45D ;
    p:P2067 wds:Q581334-06EDED36-2238-493A-9765-0CFD05FE23C3 ;
    p:P2115 wds:Q581334-A8357E2E-F1BE-43B5-85D7-E7CF18824F2A ;
    p:P2175 wds:Q581334-131AE037-5300-407D-A13E-3388A59D7969 ;
    p:P231 wds:Q581334-E45FAF39-E860-4556-A721-F2A295AC6206 ;
    p:P233 wds:Q581334-6996AD13-5167-4E92-AB75-1CFC324A5092 ;
    p:P234 wds:Q581334-AD28DAAC-5D56-4EA5-9C24-1744200E532D ;
    p:P235 wds:Q581334-5CB8BD07-21E1-4FC0-8951-5DDC417C5A42 ;
    p:P267 wds:Q581334-C573C908-C706-4CFC-8249-3326261795CB ;
    p:P274 wds:Q581334-B41B23B9-EFDD-48A7-8BE6-15F6E3D9501F ;
    p:P279 wds:Q581334-3CC1B653-F729-41F0-AFE7-27DA6B42E9D1 ;
    p:P2877 wds:Q581334-B360A766-C26B-4312-8A23-3F17DDBE6BF8 ;
    p:P2892 wds:Q581334-8ECE0419-074D-423D-A452-55D6D9DC9CC1 ;
    p:P31 wds:Q581334-25abc74e-4fce-40e7-cf31-27b5113e32e2 ;
    p:P3345 wds:Q581334-58d98295-4fcf-5f3f-745d-27c6410659d6,
        wds:Q581334-75DF3E5D-DD43-48D1-BDD3-227D363DB773 ;
    p:P3489 wds:Q581334-09BAFB80-D372-4274-9173-98F2B7424183,
        wds:Q581334-C5E26EEE-3FD0-412E-98F6-F1713F5469FF ;
    p:P366 wds:Q581334-47876E1C-A893-4C20-A0B8-3A2550A6E237,
        wds:Q581334-6B3489A9-EDA8-47CD-9946-26B7584D4C31 ;
    p:P3780 wds:Q581334-61DEE5F0-9E57-40B6-BBED-4F8E2CEB62A2,
        wds:Q581334-FBF9E2F5-D311-4AE1-8451-601F8E99FC98 ;
    p:P4527 wds:Q581334-8d0b6eb1-4c4d-2edf-9e87-4fb522dec0ef ;
    p:P486 wds:Q581334-483DB04A-1311-48B9-BD73-D6A37B6519BE ;
    p:P527 wds:Q581334-3A0B0AD3-BCCC-4CE9-8991-A6E125725B4B,
        wds:Q581334-D0E6C5F9-FE69-460E-BA6D-EBAB1CF288E9 ;
    p:P6366 wds:Q581334-10C55BD6-0DDF-43E6-A49A-BF950FB29BDC ;
    p:P646 wds:Q581334-9EF7C1DF-6C4A-49E3-9D86-7715A6AE760F ;
    p:P661 wds:Q581334-500DD799-42AA-4F62-8FAF-A4689C10958B ;
    p:P662 wds:Q581334-418D3277-71F2-4600-8E91-C7F3E01A913F ;
    p:P672 wds:Q581334-175bf10b-4b69-1eeb-7ed1-e7cc1ee21da2,
        wds:Q581334-3dd972a3-4f00-650a-27cb-6a4ae9b8e12c,
        wds:Q581334-7c665dcd-4e77-2193-69cd-eaf9bf0607d7,
        wds:Q581334-8ac44dba-4e1e-d0fe-4ecc-8dca369798e7,
        wds:Q581334-916c840d-4e45-3d97-7611-7373c7256621 ;
    wdtn:P2115 <http://purl.bioontology.org/ontology/NDFRT/N0000022222> ;
    wdtn:P4527 <http://data.parliament.uk/terms/459371> ;
    wdtn:P486 <http://id.nlm.nih.gov/mesh/D000068297> ;
    wdtn:P6366 <https://makg.org/entity/2910758946> ;
    wdtn:P661 <http://rdf.chemspider.com/7987322> ;
    wdtn:P662 <http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9811567> ;
    wdtn:P672 <http://id.nlm.nih.gov/mesh/D02.033.100.291.057.750.500>,
        <http://id.nlm.nih.gov/mesh/D02.092.063.291.057.750.500>,
        <http://id.nlm.nih.gov/mesh/D02.092.471.683.061.750.500>,
        <http://id.nlm.nih.gov/mesh/D04.210.500.054.079.129.114.500>,
        <http://id.nlm.nih.gov/mesh/D26.310.438> ;
    wdt:P10245 "a699063" ;
    wdt:P11089 "33583757" ;
    wdt:P11143 "Fluticasone/salmeterol" ;
    wdt:P2067 915.456688 ;
    wdt:P2115 "N0000022222" ;
    wdt:P2175 wd:Q3286546 ;
    wdt:P231 "136112-01-1" ;
    wdt:P267 "R03AK06" ;
    wdt:P279 wd:Q1779868 ;
    wdt:P2877 "3989" ;
    wdt:P2892 "C0939232" ;
    wdt:P31 wd:Q119892838 ;
    wdt:P3345 "284635" ;
    wdt:P3489 wd:Q28123617,
        wd:Q3679234 ;
    wdt:P366 wd:Q12140,
        wd:Q28885102 ;
    wdt:P3780 wd:Q29004394,
        wd:Q29004398 ;
    wdt:P4527 "459371" ;
    wdt:P486 "D000068297" ;
    wdt:P527 wd:Q1002165,
        wd:Q424333 ;
    wdt:P6366 "2910758946" ;
    wdt:P646 "/m/03gl20" ;
    wdt:P661 "7987322" ;
    wdt:P662 "9811567" ;
    wdt:P672 "D02.033.100.291.057.750.500",
        "D02.092.063.291.057.750.500",
        "D02.092.471.683.061.750.500",
        "D04.210.500.054.079.129.114.500",
        "D26.310.438" .